Skip to content

The Differences in the Psychological States of Patients with Different Chronic Hip Pain

Unknown statusNCT06611722
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Nowadays, studies related to the psychological state of patients with chronic hip pain are still limited, and there is a lack of research on the characteristics of the psychological state of patients with chronic soreness from different pain sources. The goal of this retrospective cross-sectional study was to reveal differences between the psychological states of chronic hip pain patients with different pain sources. The main question it aims to answer is whether there are differences in psychological states among hip pain patients with intra-hip pain, extra-hip pain, and intra-hip combined with extra-hip pain.

Study details

Official title
A Clinical Retrospective Cross-sectional Study of the Differences in the Psychological States of Patients with Different Chronic Hip Pain
Conditions
Interventions
  • Other: Psychological and Functional Assessment
Sponsor
ChunBao Li
Organization
Chinese PLA General Hospital
Start date
2023-12-05
Primary completion
2024-10-01
Sex
All
Age range
from 16 Years to 65 Years
Results posted
No results posted in this snapshot
Countries
China
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * The subject must be at least 16 years old and of sound mind; * Chronic hip pain persisting for a duration exceeding 3 months. Exclusion Criteria: * Previous mental illness and cognitive impairment; * Other serious illnesses such as heart failure, respiratory failure, malignant tumours, severe trauma and other serious illnesses;; * Chronic pain lasting for more than 3 months in other parts of the body;; * Use of prescribed opioid drugs exceeding 60 mg morphine equivalent per day or steroid analgesics.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06611722